分组1 - Quanterix Corporation reported a quarterly loss of $0.47 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.41, and compared to a loss of $0.25 per share a year ago, indicating an earnings surprise of -14.63% [1] - The company posted revenues of $24.48 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 12.62%, and down from $34.38 million in the same quarter last year [2] - Quanterix shares have declined approximately 47.2% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.57 on revenues of $41.97 million, and for the current fiscal year, it is -$1.87 on revenues of $146.48 million [7] - The Zacks Industry Rank for Medical - Products is in the bottom 37% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8]
Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates